Health ❯ Healthcare ❯ Clinical Trials

Treatment Efficacy

Patient Outcomes Combination Therapy Niktimvo Comparative Effectiveness Intravenous Administration of Leqembi Sickle Cell Disease Myeloma Treatments Asthma Treatments E1912 Trial Comparative Effectiveness Research Survival Rates Yeztugo Guselkumab vs Other Treatments Zycubo Injection Inlexzo Ruxolitinib for Vitiligo Neurological Impact Parenteral Support Reduction Alzheimer's Treatment

UK Clears Aficamten (MYQORZO) for Symptomatic Obstructive Hypertrophic Cardiomyopathy

NICE recommendation and a confidential NHS discount mean about 6,600 eligible adults could start the once‑daily pill within weeks.

NICE Recommends First Vitiligo Repigmentation Cream for NHS Use in England

FDA Approves Zycubo, First U.S. Treatment for Menkes Disease

Shorter, Chemo-Free Strategies Match or Beat Standard Care in Adult Leukemias at ASH